Navigation Links
Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline
Date:5/3/2012

SAN DIEGO, May 3, 2012 /PRNewswire/ -- Profil® Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today record growth in the number of clinical trials in the pipeline.  Profil Institute also reports an increase in the number of mid-size biotech and off-shore clients, while maintaining active collaborations with the largest global pharmaceutical companies, driven by a strong demand for Phase I and metabolic disease specialization. 

Profil Institute's advances in early phase drug research and its specific focus on diabetes, obesity and cardiometabolic diseases as it relates to the diabetic patient population have led Profil Institute to be recognized in the pharmaceutical community as the most highly regarded clinical research institute for early phase diabetes drug trials. 

"Pharmaceutical clients are facing increased pressure to be more selective and efficient with their drug candidate trials and as such are turning to specialized institutes like Profil Institute to run more complex and meaningful studies," said Profil Institute CEO Dr. Marcus Hompesch.  "While other CROs are responding to this trend, specialization has been Profil Institute's strategy since the company's inception and our business has grown as a result.  We now have a record number of projects in our pipeline, active collaborations with the largest global pharmaceutical companies, and a rapidly growing number of mid-size pharmaceutical and biotech clients."

Although considered a CRO (Clinical Research Organization), the founders of Profil Institute have never considered their company to accurately fit that description.  Instead they coined the term CRI, Clinical Research Institute, and define it as"uniting independent academic science with the professionalism of the pharmaceutical industry" – combining distinct academic intellect with the means to effec
'/>"/>

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Profil Institute Continues to Publish New Findings in Metabolic Research
2. Profiler at the cellular level
3. Genesis Biopharma Director William H. Andrews, Ph.D., Profiled in Popular Science Feature Story
4. Halozymes Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps
5. Precision Therapeutics Announces New Tumor Profiling Product to Augment Utility of ChemoFx® and Further Personalize Cancer Treatment
6. Cempra Pharmaceuticals Profiles the Broad Spectrum and Potent Activity Profile of Solithromycin (CEM-101) at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day
7. Reportlinker Adds Merck KGaA: PharmaVitae Profile
8. Reportlinker Adds Cancer Profiling and Pathways: Technologies and Global Markets
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Promega Now Offers Complete Solution for Profiling Kinase Inhibitor Compounds Against the Human Kinome
11. DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  ECC West Africa, LLC ... with University College Hospital (UCH) Ibadan Board ... project to finance, design, construct, and operate and maintain ... Nigeria . Under the first of the 4-phase ... documents and funding applications. UCH Ibadan intends to finance ...
(Date:7/24/2014)... scientists are making progress in devising suitable means ... relies on quantum dotsa kind of artificial atom, ... new study demonstrates that changing the coupling of ... impulses can help better control them. This has ... quantum information units, which would produce faster quantum ...
(Date:7/24/2014)... -- Research and Markets has announced the ... report to their offering.  ... in vitro growth of plant or animal cells for ... production. Cell culture is a crucial step in tissue ... culture consumables are necessary for the in vitro production ...
(Date:7/24/2014)... 2014 SRI International has been awarded a ... of Allergy and Infectious Diseases (NIAID), part of the ... potential therapies for HIV infection and AIDS. The contract ... AIDS and the complications and opportunistic infections associated with ... transmission of HIV. According to the ...
Breaking Biology Technology:ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3
... WA and VANCOUVER, Nov. 5 /PRNewswire-FirstCall/ - OncoGenex,Pharmaceuticals (NASDAQ: ... financial results will be released on Monday, November 10, ... and live webcast at 4:30,p.m. EDT that afternoon. Management ... update on the business and product pipeline., To ...
... 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX:ONC, NASDAQ:ONCY) ... results for the three and nine-month periods ... Decision, Oncolytics made a decision in ... randomized trial using the combination of REOLYSIN(R) ...
... N.J., Nov. 4 Cambrex,Corporation (NYSE: CBM ) reports third ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), -- Sales increased ... third quarter 2007. -- Adjusted EBITDA for the quarter was ... $9.7 million last year. -- Debt, net of cash was ...
Cached Biology Technology:OncoGenex Pharmaceuticals to Release Third Quarter Financial Results 2Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 2Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 3Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 4Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 5Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 6Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 7Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 8Oncolytics Biotech Inc. Announces 2008 Third Quarter Results 9Cambrex Reports Third Quarter 2008 Results 2Cambrex Reports Third Quarter 2008 Results 3Cambrex Reports Third Quarter 2008 Results 4Cambrex Reports Third Quarter 2008 Results 5Cambrex Reports Third Quarter 2008 Results 6Cambrex Reports Third Quarter 2008 Results 7Cambrex Reports Third Quarter 2008 Results 8Cambrex Reports Third Quarter 2008 Results 9Cambrex Reports Third Quarter 2008 Results 10Cambrex Reports Third Quarter 2008 Results 11Cambrex Reports Third Quarter 2008 Results 12Cambrex Reports Third Quarter 2008 Results 13Cambrex Reports Third Quarter 2008 Results 14
(Date:7/25/2014)... Neuregulin 1 (NRG1) is a pleiotropic factor characterized ... alternative splicing of exons that confer to the ... role for both the myelination occurring during development ... the peripheral nerve: axon degeneration, axon regrowth, remyelination ... Western Australia have discovered that the soluble NRG1 ...
(Date:7/25/2014)... development of diffusion tensor tractography (DTT), which is ... and estimation for three motor tracts, such as ... corticoreticular pathway became possible. The corticospinal tract is ... motor function in the human brain. Several studies ... by transtentorial herniation. In addition, some studies have ...
(Date:7/25/2014)... at the Stowers Institute for Medical Research ... receptors, and found pheromones crucial to triggering the mating ... receptors helps a male mouse detect pheromones that indicate ... receptors lets him know if the female mouse is ... are critical to trigger mating. Stowers, researchers believe mice ...
Breaking Biology News(10 mins):It takes two to court 2It takes two to court 3
... and Yuh Nung Jan, PhD, of the Howard Hughes ... will jointly receive the 2012 Neuroscience Prize of The ... contributions to the field of molecular neurobiology, particularly their ... activity and on how brain cells diversify and specialize ...
... Calif.) You pick up your cell phone and dial ... At. A. Time. Because you haven,t actually typed the number ... sequence of distinct movements. After dialing the number a ... a series of three successive bursts of movement: the area ...
... use plants as ,green phones, for communication with other ... same plants insects are also able to leave ,voicemail, ... via their effects on soil fungi. Researchers from the ... discovered this unique messaging service in the ragwort plant. ...
Cached Biology News:UCSF pair win Gruber Foundation Neuroscience prize 2UCSF pair win Gruber Foundation Neuroscience prize 3UCSF pair win Gruber Foundation Neuroscience prize 4Study by UC Santa Barbara psychologists reveals how brain performs 'motor chunking' tasks 2Study by UC Santa Barbara psychologists reveals how brain performs 'motor chunking' tasks 3Voicemail discovered in nature 2
... loxP-PGK-gb2-neo-loxP template is designed to allow ... cells. The loxP-PGK-gb2-neo-loxP template encodes ... a prokaryotic promoter (gb2) for expression ... a eukaryotic promoter (PGK) for expression ...
... depletion cocktail is tailored to ... from suspensions of rat spleen ... the StemSep (or compatible 0.5 ... system. The CD4+ T cell ...
Standard Fluka For microscopy (Hist.) redox indicator...
... The VSOS-4 Orbital Shaker is designed ... to provide a uniform motion that is both ... The VSOS-4 Orbital Shaker provides a smooth, quiet, ... for a wide range of laboratory applications such ...
Biology Products: